Sound Income Strategies’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
MAP
CGH
Sound Income Strategies's TAK Position: Q2 2026 in Review
Sound Income Strategies sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 1,286 shares — an estimated $24.1K sold.
Sound Income Strategies first reported a position in TAK in Q1 2019 and held it in 20 quarters. The position peaked at $24.1K in Q1 2026. 265 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- Sound Income Strategies reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
- Sound Income Strategies sold 1,286 Takeda Pharmaceutical shares in Q2 2026, an estimated $24.1K.
- Sound Income Strategies first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 20 quarters.
- Sound Income Strategies's Takeda Pharmaceutical position peaked at $24.1K in Q1 2026.
- 265 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.